Numerical values of data in Figs 1–6 and S1–S6 Figs.
<p>Numerical values of data in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003490#pbio.3003490.g001" target="_blank">Figs 1</a>–<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003490#pbio.3003490....
Uloženo v:
| Hlavní autor: | Fengyi Mao (15073242) (author) |
|---|---|
| Další autoři: | Sai Wu (6096290) (author), Derek B. Allison (15141675) (author), Daheng He (9189701) (author), Yifan Kong (4458616) (author), Chaohao Li (15141681) (author), Zhiguo Li (431917) (author), Yanquan Zhang (14930570) (author), Xinyi Wang (559030) (author), Qiongsi Zhang (2818111) (author), Chi Wang (131921) (author), Xiaoqi Liu (45630) (author) |
| Vydáno: |
2025
|
| Témata: | |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma.
Autor: Fengyi Mao (15073242)
Vydáno: (2025) -
BTB domain and CNC homolog 1 (BACH1) is stabilized by Polo-like kinase 1 (PLK1).
Autor: Fengyi Mao (15073242)
Vydáno: (2025) -
Knockdown of BTB domain and CNC homolog 1 (BACH1) impedes Polo-like kinase 1 (PLK1)-induced phenotype in melanoma.
Autor: Fengyi Mao (15073242)
Vydáno: (2025) -
Polo-like kinase 1 (PLK1) induces Vemurafenib resistance in melanoma.
Autor: Fengyi Mao (15073242)
Vydáno: (2025) -
Overexpressed Polo-like kinase 1 (PLK1) promotes metastasis and metabolic reprogramming in melanoma.
Autor: Fengyi Mao (15073242)
Vydáno: (2025)